A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 41
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Crry
Long Form : complement receptor 1-related gene/protein y
No. Year Title Co-occurring Abbreviation
2021 Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice. DKD, DMOG, MAC, MPTECs, SGLT2
2021 Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. ALI, C3a, EC, LDH
2021 Hemopexin Modulates Expression of Complement Regulatory Proteins in Rat Glomeruli. DAF, HO, HPX
2021 Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury. CHI, CR2-Crry, iNSCs
2020 C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice. CAIA, CDA, CIA, NAbs
2020 Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth. ---
2018 Induced neural stem cell-derived astrocytes modulate complement activation and mediate neuroprotection following closed head injury. CHI, iNSCs
2018 Sialic acid is a critical fetal defense against maternal complement attack. CMAS, Sia
2018 The Alternative Complement System Mediates Cell Death in Retinal Ischemia Reperfusion Injury. HRECs, IOP, IR
10  2017 Systemic Administration of Induced Neural Stem Cells Regulates Complement Activation in Mouse Closed Head Injury Models. CHI, CNS, iNSCs
11  2016 Depression of Complement Regulatory Factors in Rat and Human Renal Grafts Is Associated with the Progress of Acute T-Cell Mediated Rejection. ATCMR, MCP, qRT-PCR
12  2016 Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. GD, qRT-PCR, RUPP
13  2015 Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. CREAE, MS
14  2014 Effects of endosulfan on the immune function of erythrocytes, and potential protection by testosterone propionate. E-IC, EC3bR, RFER, RFIR, TP
15  2013 Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. DAF
16  2013 Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats. CDC, mCRPs
17  2012 C3-dependent mechanism of microglial priming relevant to multiple sclerosis. EAE, MS
18  2008 Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy. DAF, mCRPs, PDT
19  2008 Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. ---
20  2008 Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. CR3, DAF
21  2007 Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b. FI, iC3b, OE
22  2006 Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. I/R
23  2006 DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity. DAF
24  2006 Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack. DAF
25  2005 In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane. ---
26  2004 Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. AHR, BAL, CVF
27  2004 Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis. AChR, DAF, EAMG, EOM, mAb, MG
28  2004 Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects. AP, sCrry
29  2004 The role of rat Crry, a complement regulatory protein, in proliferation of thymocytes. APC, Con A, IL-2, IL-2R alpha, mAb, TCR
30  2003 Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. ---
31  2003 Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition. DAF, EC, GPI, mAb, MAPK, NF-kappaB, PI-3 kinase, PKC, RT-PCR, TNF-alpha
32  2003 Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. ---
33  2003 Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. IL
34  2003 Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y. CIA, WT
35  2003 The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy. rCrry, SCR
36  2002 Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. aPL, APS
37  2002 Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. AIHA, DAF, FcgammaR, IgG2a
38  2001 Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. FACS, GPI, GPI-DAF, TM
39  2001 Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. ---
40  1998 Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. Abs, Ig, NTS, rs, RT-PCR
41  1996 Molecular cloning of murine decay accelerating factor by immunoscreening. DAF, SCR